The Royal Melbourne Hospital, located in Parkville, Victoria, an inner suburb of Melbourne, is one of Australia's leading public hospitals. It is a major teaching hospital for tertiary health care with a reputation in clinical research.

There are 571 beds in Melbourne Health.

During the past decade, Melbourne Health conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Melbourne Health" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Biotronik Canada Inc" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Eastern Health" with 1 trials as a collaborator and "Melbourne Health" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Melbourne Health" are "Amyotrophic Lateral Sclerosis" (1 trials), "Atrial Fibrillation" (1 trials), "Critical Illness" (1 trials), "Leukemia, Lymphoblastic, Acute, L1" (1 trials) and "Leukemia, Lymphoblastic, Acute, L2" (1 trials). Many other conditions were trialed in "Melbourne Health" in a lesser frequency.

Most popular intervention types in "Melbourne Health" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetylsalicylic acid" (1 trials), "Botulinum Toxin Type A" (1 trials), "Cyclophosphamide" (1 trials), "Fludarabine" (1 trials) and "Motor Neuroprosthesis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Melbourne Health" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Melbourne Health". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Melbourne Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Melbourne Health, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".